GO:0010467 | gene expression | 3.24e-05 | 3.17e-01 | 3.075 | 6 | 49 | 535 |
GO:0000398 | mRNA splicing, via spliceosome | 5.72e-04 | 1.00e+00 | 4.138 | 3 | 15 | 128 |
GO:0008380 | RNA splicing | 1.20e-03 | 1.00e+00 | 3.772 | 3 | 21 | 165 |
GO:0004832 | valine-tRNA ligase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0005515 | protein binding | 2.23e-03 | 1.00e+00 | 1.003 | 11 | 198 | 4124 |
GO:0004656 | procollagen-proline 4-dioxygenase activity | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0016222 | procollagen-proline 4-dioxygenase complex | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0033688 | regulation of osteoblast proliferation | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0090400 | stress-induced premature senescence | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0005654 | nucleoplasm | 4.01e-03 | 1.00e+00 | 2.100 | 5 | 68 | 876 |
GO:0001649 | osteoblast differentiation | 4.19e-03 | 1.00e+00 | 4.344 | 2 | 5 | 74 |
GO:0042582 | azurophil granule | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0034773 | histone H4-K20 trimethylation | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0036089 | cleavage furrow formation | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 2 | 4 |
GO:0005925 | focal adhesion | 5.50e-03 | 1.00e+00 | 2.998 | 3 | 14 | 282 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 5 |
GO:0051525 | NFAT protein binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0043931 | ossification involved in bone maturation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 6 |
GO:0043297 | apical junction assembly | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0006903 | vesicle targeting | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0010831 | positive regulation of myotube differentiation | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0003756 | protein disulfide isomerase activity | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0004707 | MAP kinase activity | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0042581 | specific granule | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0003924 | GTPase activity | 1.05e-02 | 1.00e+00 | 3.658 | 2 | 7 | 119 |
GO:0090307 | spindle assembly involved in mitosis | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 2 | 8 |
GO:0004708 | MAP kinase kinase activity | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0019395 | fatty acid oxidation | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 4 | 8 |
GO:0043296 | apical junction complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0032495 | response to muramyl dipeptide | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0045663 | positive regulation of myoblast differentiation | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0006184 | GTP catabolic process | 1.25e-02 | 1.00e+00 | 3.531 | 2 | 7 | 130 |
GO:0070062 | extracellular vesicular exosome | 1.31e-02 | 1.00e+00 | 1.458 | 6 | 51 | 1641 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0050919 | negative chemotaxis | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0030168 | platelet activation | 1.45e-02 | 1.00e+00 | 3.413 | 2 | 5 | 141 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 4 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 11 |
GO:0042307 | positive regulation of protein import into nucleus | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 3 | 12 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 12 |
GO:0061025 | membrane fusion | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0050772 | positive regulation of axonogenesis | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0001502 | cartilage condensation | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 15 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 16 |
GO:0032467 | positive regulation of cytokinesis | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 2 | 16 |
GO:0045648 | positive regulation of erythrocyte differentiation | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 2 | 17 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 18 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 2 | 18 |
GO:0030316 | osteoclast differentiation | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 18 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 19 |
GO:0071897 | DNA biosynthetic process | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0005525 | GTP binding | 2.73e-02 | 1.00e+00 | 2.931 | 2 | 12 | 197 |
GO:0000077 | DNA damage checkpoint | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 4 | 21 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 1 | 21 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.78e-02 | 1.00e+00 | 2.916 | 2 | 8 | 199 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 2 | 22 |
GO:0002062 | chondrocyte differentiation | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 2 | 22 |
GO:0019899 | enzyme binding | 3.07e-02 | 1.00e+00 | 2.839 | 2 | 7 | 210 |
GO:0003677 | DNA binding | 3.08e-02 | 1.00e+00 | 1.666 | 4 | 52 | 947 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 6 | 24 |
GO:0071479 | cellular response to ionizing radiation | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 2 | 24 |
GO:0005634 | nucleus | 3.40e-02 | 1.00e+00 | 0.889 | 8 | 158 | 3246 |
GO:0051496 | positive regulation of stress fiber assembly | 3.41e-02 | 1.00e+00 | 4.853 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 4 | 27 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 1 | 27 |
GO:0005737 | cytoplasm | 3.61e-02 | 1.00e+00 | 0.998 | 7 | 127 | 2633 |
GO:0042692 | muscle cell differentiation | 3.67e-02 | 1.00e+00 | 4.746 | 1 | 2 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 6 | 29 |
GO:0032154 | cleavage furrow | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 3 | 30 |
GO:0034976 | response to endoplasmic reticulum stress | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 2 | 31 |
GO:0045454 | cell redox homeostasis | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 3 | 31 |
GO:0003723 | RNA binding | 4.14e-02 | 1.00e+00 | 2.605 | 2 | 22 | 247 |
GO:0042157 | lipoprotein metabolic process | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 4 | 32 |
GO:0006892 | post-Golgi vesicle-mediated transport | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 1 | 32 |
GO:0007519 | skeletal muscle tissue development | 4.31e-02 | 1.00e+00 | 4.509 | 1 | 2 | 33 |
GO:0021762 | substantia nigra development | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 1 | 34 |
GO:0000902 | cell morphogenesis | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 5 | 35 |
GO:0050434 | positive regulation of viral transcription | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 2 | 35 |
GO:0030334 | regulation of cell migration | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 2 | 36 |
GO:0003743 | translation initiation factor activity | 4.82e-02 | 1.00e+00 | 4.344 | 1 | 8 | 37 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 4.95e-02 | 1.00e+00 | 4.305 | 1 | 2 | 38 |
GO:0006396 | RNA processing | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 6 | 40 |
GO:0005739 | mitochondrion | 5.26e-02 | 1.00e+00 | 1.774 | 3 | 32 | 659 |
GO:0051403 | stress-activated MAPK cascade | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 2 | 42 |
GO:0006887 | exocytosis | 5.71e-02 | 1.00e+00 | 4.094 | 1 | 1 | 44 |
GO:0032481 | positive regulation of type I interferon production | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 3 | 48 |
GO:0034146 | toll-like receptor 5 signaling pathway | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 3 | 50 |
GO:0034166 | toll-like receptor 10 signaling pathway | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 3 | 50 |
GO:0018105 | peptidyl-serine phosphorylation | 6.58e-02 | 1.00e+00 | 3.881 | 1 | 2 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.71e-02 | 1.00e+00 | 3.853 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 3 | 53 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 7.08e-02 | 1.00e+00 | 3.772 | 1 | 3 | 55 |
GO:0034162 | toll-like receptor 9 signaling pathway | 7.08e-02 | 1.00e+00 | 3.772 | 1 | 3 | 55 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 7.08e-02 | 1.00e+00 | 3.772 | 1 | 3 | 55 |
GO:0005829 | cytosol | 7.21e-02 | 1.00e+00 | 1.072 | 5 | 88 | 1787 |
GO:0034134 | toll-like receptor 2 signaling pathway | 7.21e-02 | 1.00e+00 | 3.746 | 1 | 3 | 56 |
GO:0007596 | blood coagulation | 7.28e-02 | 1.00e+00 | 2.148 | 2 | 13 | 339 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 7.33e-02 | 1.00e+00 | 3.720 | 1 | 2 | 57 |
GO:0042826 | histone deacetylase binding | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 5 | 58 |
GO:0006935 | chemotaxis | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 2 | 58 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 2 | 58 |
GO:0034138 | toll-like receptor 3 signaling pathway | 7.58e-02 | 1.00e+00 | 3.670 | 1 | 2 | 59 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 7.58e-02 | 1.00e+00 | 3.670 | 1 | 5 | 59 |
GO:0007265 | Ras protein signal transduction | 7.58e-02 | 1.00e+00 | 3.670 | 1 | 3 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 5 | 61 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 4 | 61 |
GO:0000187 | activation of MAPK activity | 8.07e-02 | 1.00e+00 | 3.576 | 1 | 3 | 63 |
GO:0042470 | melanosome | 8.20e-02 | 1.00e+00 | 3.553 | 1 | 3 | 64 |
GO:0071222 | cellular response to lipopolysaccharide | 8.20e-02 | 1.00e+00 | 3.553 | 1 | 2 | 64 |
GO:0044822 | poly(A) RNA binding | 8.42e-02 | 1.00e+00 | 1.496 | 3 | 45 | 799 |
GO:0000922 | spindle pole | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 4 | 68 |
GO:0006928 | cellular component movement | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 6 | 70 |
GO:0030308 | negative regulation of cell growth | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 3 | 70 |
GO:0030496 | midbody | 9.30e-02 | 1.00e+00 | 3.363 | 1 | 6 | 73 |
GO:0034142 | toll-like receptor 4 signaling pathway | 9.30e-02 | 1.00e+00 | 3.363 | 1 | 3 | 73 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 2 | 76 |
GO:0071456 | cellular response to hypoxia | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 9.79e-02 | 1.00e+00 | 3.286 | 1 | 6 | 77 |
GO:0006006 | glucose metabolic process | 1.01e-01 | 1.00e+00 | 3.231 | 1 | 3 | 80 |
GO:0030529 | ribonucleoprotein complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.05e-01 | 1.00e+00 | 3.178 | 1 | 2 | 83 |
GO:0045202 | synapse | 1.05e-01 | 1.00e+00 | 3.178 | 1 | 3 | 83 |
GO:0002224 | toll-like receptor signaling pathway | 1.05e-01 | 1.00e+00 | 3.178 | 1 | 3 | 83 |
GO:0005524 | ATP binding | 1.09e-01 | 1.00e+00 | 1.337 | 3 | 37 | 892 |
GO:0016032 | viral process | 1.09e-01 | 1.00e+00 | 1.811 | 2 | 30 | 428 |
GO:0030027 | lamellipodium | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 3 | 88 |
GO:0007166 | cell surface receptor signaling pathway | 1.12e-01 | 1.00e+00 | 3.077 | 1 | 3 | 89 |
GO:0061024 | membrane organization | 1.12e-01 | 1.00e+00 | 3.077 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 1.13e-01 | 1.00e+00 | 3.061 | 1 | 4 | 90 |
GO:0045087 | innate immune response | 1.19e-01 | 1.00e+00 | 1.733 | 2 | 12 | 452 |
GO:0006457 | protein folding | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.24e-01 | 1.00e+00 | 2.924 | 1 | 6 | 99 |
GO:0005788 | endoplasmic reticulum lumen | 1.30e-01 | 1.00e+00 | 2.853 | 1 | 4 | 104 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.34e-01 | 1.00e+00 | 2.811 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.35e-01 | 1.00e+00 | 2.798 | 1 | 2 | 108 |
GO:0042981 | regulation of apoptotic process | 1.39e-01 | 1.00e+00 | 2.746 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 1.41e-01 | 1.00e+00 | 2.733 | 1 | 6 | 113 |
GO:0007049 | cell cycle | 1.43e-01 | 1.00e+00 | 2.707 | 1 | 8 | 115 |
GO:0044212 | transcription regulatory region DNA binding | 1.75e-01 | 1.00e+00 | 2.393 | 1 | 13 | 143 |
GO:0001525 | angiogenesis | 1.78e-01 | 1.00e+00 | 2.363 | 1 | 2 | 146 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.94e-01 | 1.00e+00 | 2.222 | 1 | 18 | 161 |
GO:0007165 | signal transduction | 1.97e-01 | 1.00e+00 | 1.282 | 2 | 24 | 618 |
GO:0016071 | mRNA metabolic process | 2.04e-01 | 1.00e+00 | 2.144 | 1 | 10 | 170 |
GO:0007264 | small GTPase mediated signal transduction | 2.09e-01 | 1.00e+00 | 2.110 | 1 | 8 | 174 |
GO:0000166 | nucleotide binding | 2.11e-01 | 1.00e+00 | 2.094 | 1 | 13 | 176 |
GO:0006412 | translation | 2.13e-01 | 1.00e+00 | 2.077 | 1 | 12 | 178 |
GO:0005575 | cellular_component | 2.22e-01 | 1.00e+00 | 2.006 | 1 | 4 | 187 |
GO:0016070 | RNA metabolic process | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 10 | 188 |
GO:0005856 | cytoskeleton | 2.26e-01 | 1.00e+00 | 1.983 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 9 | 197 |
GO:0004674 | protein serine/threonine kinase activity | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 8 | 197 |
GO:0035556 | intracellular signal transduction | 2.35e-01 | 1.00e+00 | 1.916 | 1 | 5 | 199 |
GO:0015031 | protein transport | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 10 | 203 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 14 | 203 |
GO:0006281 | DNA repair | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 24 | 203 |
GO:0006355 | regulation of transcription, DNA-templated | 2.46e-01 | 1.00e+00 | 1.071 | 2 | 31 | 715 |
GO:0030054 | cell junction | 2.54e-01 | 1.00e+00 | 1.785 | 1 | 5 | 218 |
GO:0030198 | extracellular matrix organization | 2.58e-01 | 1.00e+00 | 1.765 | 1 | 7 | 221 |
GO:0007411 | axon guidance | 2.74e-01 | 1.00e+00 | 1.664 | 1 | 8 | 237 |
GO:0046982 | protein heterodimerization activity | 3.01e-01 | 1.00e+00 | 1.503 | 1 | 11 | 265 |
GO:0008150 | biological_process | 3.06e-01 | 1.00e+00 | 1.476 | 1 | 3 | 270 |
GO:0008285 | negative regulation of cell proliferation | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 11 | 277 |
GO:0009986 | cell surface | 3.25e-01 | 1.00e+00 | 1.368 | 1 | 5 | 291 |
GO:0003674 | molecular_function | 3.31e-01 | 1.00e+00 | 1.339 | 1 | 4 | 297 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.49e-01 | 1.00e+00 | 1.245 | 1 | 17 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.70e-01 | 1.00e+00 | 1.139 | 1 | 23 | 341 |
GO:0044267 | cellular protein metabolic process | 3.80e-01 | 1.00e+00 | 1.094 | 1 | 14 | 352 |
GO:0042802 | identical protein binding | 3.81e-01 | 1.00e+00 | 1.085 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.01e-01 | 1.00e+00 | 0.995 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 4.04e-01 | 1.00e+00 | 0.979 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 4.28e-01 | 1.00e+00 | 0.870 | 1 | 15 | 411 |
GO:0006351 | transcription, DNA-templated | 4.28e-01 | 1.00e+00 | 0.482 | 2 | 47 | 1076 |
GO:0005886 | plasma membrane | 4.33e-01 | 1.00e+00 | 0.337 | 3 | 46 | 1784 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.63e-01 | 1.00e+00 | 0.720 | 1 | 29 | 456 |
GO:0016020 | membrane | 4.90e-01 | 1.00e+00 | 0.316 | 2 | 56 | 1207 |
GO:0005730 | nucleolus | 4.95e-01 | 1.00e+00 | 0.304 | 2 | 74 | 1217 |
GO:0005887 | integral component of plasma membrane | 5.46e-01 | 1.00e+00 | 0.386 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.88e-01 | 1.00e+00 | 0.222 | 1 | 29 | 644 |
GO:0005576 | extracellular region | 5.99e-01 | 1.00e+00 | 0.180 | 1 | 15 | 663 |
GO:0008270 | zinc ion binding | 6.34e-01 | 1.00e+00 | 0.047 | 1 | 39 | 727 |
GO:0044281 | small molecule metabolic process | 6.91e-01 | 1.00e+00 | -0.168 | 1 | 35 | 844 |